from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2036/-

LFCtreatmentdescriptionclass of inhibitor

1.005

Amikacinug/mL Amikacintranslation

0.373

Cap5-10ug/mL Capreomycintranslation

0.557

Rox10-50 ug/mL Roxithromycintranslation

0.612

SM2-5 ug/mL Streptomycintranslation

0.381

Tet5-10 ug/mL Tetracyclinetranslation

0.358

Rif0.2-5ug/mL Rifampicintranscription

-0.240

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.168

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.966

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.011

CPZ10-50 ug/mL Chlorpromazinerespiration

0.304

Clofazimine10-13 ug/mL Clofaziminerespiration

0.025

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.170

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.116

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.273

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.250

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.156

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.173

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.296

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.163

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.283

KCN5-20 ug/mL Potassium cyaniderespiration

0.410

NaN30.2-2 mM Sodium aziderespiration

-0.434

Nigericin50 uM Nigericinrespiration

0.781

TRC10-150 ug/mL Triclosanrespiration

0.931

TRZ10-25 ug/mL Thioridazinerespiration

3.190

Valinomycin0.5-10 uM Valinomycinrespiration

-0.370

ZnSO42 mM ZnSO4respiration

-0.386

menadione6-10 ug/mL Menadionerespiration

-0.238

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.590

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.360

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.821

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.373

NRP_1Non-replicating persistence stage 1dosRassociated

-0.912

Amp0.2mg/mL AmpicillincellWall

-0.343

Cephalexin20-100 ug/mL CephalexincellWall

-0.226

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.733

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.692

EMB10-20 ug/mL EthambutolcellWall

-0.574

Eta12-40 ug/mL EthionamidecellWall

-1.026

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.690

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.715

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.144

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.000

BZA0.12 mg/mL BenzamidearomaticAmides

0.280

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.727

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.102

H2O24 mM hydrogen peroxideDNAdamaging

-0.521

Levo10 ug/mL LevofloxacinDNAdamaging

-0.478

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.530

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.848

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.942

UVUV-irradiationDNAdamaging

0.452

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.128

Antimycin12.5-50 ug/mL Antimycin A?

-0.400

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.101

PA_110-50 ug/mL Antitubercular compound PA-1?

0.054

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.223

PA8240.2-2 ug/mL PA-824?

0.749

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.232

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.523

Verapamil50 uM Verapamil?

-0.909

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.963

methoxatin10-20 ug/mL Methoxatin?